Contacts
Corporate Communications Contacts
Mrs Jessica Mann
SVP, Global Corporate Communications
Tel: +44 (0) 1256 894280
Mobile: +44 (0) 7787127907
Fax: +44 (0) 1256 894708
Email: jmann@uk.shire.com
Mrs Sonia Whyte
Corporate Responsibility/Internal Communications Co-Ordinator
Tel: +44 (0) 1256 894 601
Fax: +44 (0) 1256 894700
E-mail: swhyte@uk.shire.com
Mr Souheil Salah
Associate Corporate Communications/Investor Relations
Tel: +44 (0) 1256 894160
Fax: +44 (0) 1256 894815
Email: ssalah@uk.shire.com
Latest Press Releases
- Shire delivers strong quarter driven by 3m of new product sales
- Jerini receives european commission approval for FIRAZYR® (Icatibant) in HAE treatment
- Shire to add new orphan drug to its HGT portfolio - EU launch imminnent
- Graham Hetherington appointed Chief Financial Officer and Board Director at Shire
- First and Only Treatment for Hunter Syndrome Now Approved in 40 Countries Worldwide
- Results of Court Meeting and Extraordinary General Meeting - Shareholders Approve Scheme of Arrangement and New Share Plans
- Shire welcomes the Court of Appeal's decision that NICE review of Alzheimer's drugs was procedurally unfair
- Publication of Supplementary Prospectus
- Shire enhances its orphan drug pipeline with the acquisition of a new clinical candidate for Metachromatic Leukodystrophy
- FDA Approves VYVANSE (TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults

